GENMAB A/S -SP ADR (GMAB) Stock Analyst Ratings
USA - NASDAQ:GMAB - US3723032062 - ADR
28.84 USD
-0.35 (-1.2%)
28.84 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 75% to GMAB. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 135.67. This target is 370.42% above the current price.
GMAB was analyzed by 26 analysts. The buy percentage consensus is at 75. So analysts seem to be have mildly positive about GMAB.
In the previous month the buy percentage consensus was at a similar level.
GMAB was analyzed by 26 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-10-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-10-02 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-09-24 | Guggenheim | Upgrade | Neutral -> Buy |
| 2025-09-23 | Guggenheim | Upgrade | Neutral -> Buy |
| 2025-08-15 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-07-08 | Truist Securities | Maintains | Buy -> Buy |
| 2025-04-09 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-11 | William Blair | Upgrade | Market Perform -> Outperform |
| 2025-03-11 | Truist Securities | Maintains | Buy -> Buy |
| 2025-02-13 | Leerink Partners | Upgrade | Market Perform -> Outperform |
| 2025-01-23 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-22 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-08 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-11-08 | BMO Capital | Reiterate | Outperform -> Outperform |
| 2024-10-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-20 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-11 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2024-09-09 | Truist Securities | Maintains | Buy -> Buy |
| 2024-09-04 | Morgan Stanley | Reiterate | Equal-Weight |
| 2024-08-27 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-20 | JP Morgan | Downgrade | Overweight -> Neutral |
| 2024-08-20 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-09 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-06 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-01 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-07-18 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-07-15 | RBC Capital | Upgrade | Sector Perform -> Outperform |
| 2024-06-27 | BTIG | Maintains | Buy -> Buy |
GENMAB A/S -SP ADR / GMAB FAQ
What is the average price target for GENMAB A/S -SP ADR (GMAB) stock?
26 analysts have analysed GMAB and the average price target is 59.71 USD. This implies a price increase of 107.04% is expected in the next year compared to the current price of 28.84.
What is the consensus rating for GENMAB A/S -SP ADR (GMAB) stock?
The consensus rating for GENMAB A/S -SP ADR (GMAB) is 74.6154 / 100 . This indicates that analysts generally have a positive outlook on the stock.
What is the number of analysts for GMAB stock?
The number of analysts covering GENMAB A/S -SP ADR (GMAB) is 26.